Published in Eur Arch Psychiatry Clin Neurosci on July 27, 2011
Looking at the other side of the coin: a meta-analysis of self-reported emotional arousal in people with schizophrenia. Schizophr Res (2012) 1.03
A negative emotional and economic judgment bias in major depression. Eur Arch Psychiatry Clin Neurosci (2013) 0.78
Neural correlates of aberrant emotional salience predict psychotic symptoms and global functioning in high-risk and first-episode psychosis. Soc Cogn Affect Neurosci (2015) 0.78
The relation between schizotypy and early attention to rejecting interactions: The influence of neuroticism. World J Biol Psychiatry (2015) 0.77
Trait and state positive emotional experience in schizophrenia: a meta-analysis. PLoS One (2012) 0.77
Dorsal raphe neuroinflammation promotes dramatic behavioral stress dysregulation. J Neurosci (2014) 0.77
Body actions change the appearance of facial expressions. PLoS One (2014) 0.76
Emotional status: diagnosis and treatment for severe psychiatric disorders. Eur Arch Psychiatry Clin Neurosci (2012) 0.75
New aspects of the vulnerability stress model in general, its relevance in schizophrenic psychoses and the place of antipsychotics. Eur Arch Psychiatry Clin Neurosci (2017) 0.75
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
Emotion circuits in the brain. Annu Rev Neurosci (2000) 24.39
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry (2003) 10.07
Rethinking feelings: an FMRI study of the cognitive regulation of emotion. J Cogn Neurosci (2002) 9.33
Valence, gender, and lateralization of functional brain anatomy in emotion: a meta-analysis of findings from neuroimaging. Neuroimage (2003) 3.76
Emotional response deficits in schizophrenia: insights from affective science. Schizophr Bull (2008) 2.90
Emotional experience in patients with schizophrenia revisited: meta-analysis of laboratory studies. Schizophr Bull (2008) 2.75
Facial emotion recognition in schizophrenia: intensity effects and error pattern. Am J Psychiatry (2003) 2.69
Emotional experience and expression in schizophrenia and depression. J Abnorm Psychol (1992) 2.62
The neural bases of distraction and reappraisal. J Cogn Neurosci (2010) 2.58
Suspicious minds: the psychology of persecutory delusions. Clin Psychol Rev (2007) 2.30
A salience dysregulation syndrome. Br J Psychiatry (2009) 2.23
Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophr Bull (1998) 2.23
Emotional reactivity to daily life stress in psychosis. Arch Gen Psychiatry (2001) 2.20
Do schizophrenic patients show a disjunctive relationship among expressive, experiential, and psychophysiological components of emotion? J Abnorm Psychol (1996) 2.06
From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis. Schizophr Res (2005) 2.00
Flat affect in schizophrenia does not reflect diminished subjective experience of emotion. J Abnorm Psychol (1993) 1.83
Affective traits in schizophrenia and schizotypy. Schizophr Bull (2008) 1.81
Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry (2004) 1.70
Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol (2005) 1.69
On the broad applicability of the affective circumplex: representations of affective knowledge among schizophrenia patients. Psychol Sci (2003) 1.64
Impairment in the specificity of emotion processing in schizophrenia. Am J Psychiatry (2006) 1.58
The formation of abnormal associations in schizophrenia: neural and behavioral evidence. Neuropsychopharmacology (2007) 1.56
Connecting neurosis and psychosis: the direct influence of emotion on delusions and hallucinations. Behav Res Ther (2003) 1.46
Neural response to emotional salience in schizophrenia. Neuropsychopharmacology (2005) 1.42
Overactivation of fear systems to neutral faces in schizophrenia. Biol Psychiatry (2008) 1.38
Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. Am J Psychiatry (2003) 1.37
Regions of the MPFC differentially tuned to social and nonsocial affective evaluation. Cogn Affect Behav Neurosci (2007) 1.33
Explaining delusions: a cognitive perspective. Trends Cogn Sci (2006) 1.32
In support of Bleuler: objective evidence for increased affective ambivalence in schizophrenia based upon evocative testing. Schizophr Res (2008) 1.27
Schizophrenia and personality: exploring the boundaries and connections between vulnerability and outcome. J Abnorm Psychol (1994) 1.17
A reversal of the normal pattern of parahippocampal response to neutral and fearful faces is associated with reality distortion in schizophrenia. Biol Psychiatry (2006) 1.16
Increased neural response related to neutral faces in individuals at risk for psychosis. Neuroimage (2007) 1.15
Physiological responsivity to emotional pictures in schizophrenia. J Psychiatr Res (2005) 1.10
Negative schizophrenic symptoms and the frontal lobe syndrome: one and the same? Eur Arch Psychiatry Clin Neurosci (2010) 1.09
A neuropsychiatric model of biological and psychological processes in the remission of delusions and auditory hallucinations. Schizophr Bull (2006) 1.07
The misattribution of salience in delusional patients with schizophrenia. Schizophr Res (2006) 1.02
Facial affect recognition in the course of schizophrenia. Eur Arch Psychiatry Clin Neurosci (1996) 1.01
Perception of socially relevant stimuli in schizophrenia. Schizophr Res (2006) 1.00
Social cognition: the key factor predicting social outcome in people with schizophrenia? Psychiatry (Edgmont) (2010) 0.99
The ICD-10 symptom checklist: a companion to the ICD-10 classification of mental and behavioural disorders. Soc Psychiatry Psychiatr Epidemiol (1993) 0.98
Reappraisal of the interplay between psychosis and depression symptoms in the pathogenesis of psychotic syndromes: results from a twenty-year prospective community study. Eur Arch Psychiatry Clin Neurosci (2010) 0.96
Perception of threat in schizophrenics with persecutory delusions: an investigation using visual scan paths. Psychol Med (2000) 0.92
Emotional experience predicts social adjustment independent of neurocognition and social cognition in schizophrenia. Schizophr Res (2010) 0.85
Gender differences in facial emotion recognition in persons with chronic schizophrenia. Eur Psychiatry (2006) 0.83
Deficit of social cognition in subjects with surgically treated frontal lobe lesions and in subjects affected by schizophrenia. Eur Arch Psychiatry Clin Neurosci (2007) 0.83
Reasoning under uncertainty: heuristic judgments in patients with persecutory delusions or depression. Psychol Med (2006) 0.83
Social skills and neurocognitive individualized training in schizophrenia: comparison with structured leisure activities. Eur Arch Psychiatry Clin Neurosci (2009) 0.82
Schizophrenia. A cognitive model and its implications for psychological intervention. Behav Modif (1996) 0.82
Differential subjective and psychophysiological responses to socially and nonsocially generated emotional stimuli. Emotion (2006) 0.82
Emotion in the daily lives of schizophrenia patients: context matters. Schizophr Res (2009) 0.81
Social cognition in schizophrenia: similarities and differences of emotional perception from patients with focal frontal lesions. Eur Arch Psychiatry Clin Neurosci (2009) 0.78
Dual-stream modulation failure: a novel hypothesis for the formation and maintenance of delusions in schizophrenia. Med Hypotheses (2008) 0.76
[Emotional processes in schizophrenia: investigation of the evaluative component]. Encephale (2006) 0.75
The psychosis continuum: diagnosis and other phenotypes. Eur Arch Psychiatry Clin Neurosci (2011) 0.75
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet (2008) 10.52
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet (2009) 5.01
Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet (2008) 4.78
Identifying depression in primary care: a comparison of different methods in a prospective cohort study. BMJ (2003) 3.78
Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data. Int J Neuropsychopharmacol (2010) 2.74
The diagnosis and treatment of generalized anxiety disorder. Dtsch Arztebl Int (2013) 2.73
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry (2008) 2.64
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. World J Biol Psychiatry (2007) 2.40
Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry (2009) 2.17
Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry (2002) 2.15
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. J Clin Psychiatry (2009) 2.09
Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry (2007) 2.05
Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment. Neuroimage (2007) 2.03
Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. Brain (2005) 2.03
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia. World J Biol Psychiatry (2005) 1.98
Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness. Am J Psychiatry (2011) 1.94
Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection. Neuroimage (2004) 1.84
Prefrontal transcranial direct current stimulation changes connectivity of resting-state networks during fMRI. J Neurosci (2011) 1.81
Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. Arch Neurol (2005) 1.75
Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism. Arch Gen Psychiatry (2008) 1.75
Factor structure and external validity of the PANSS revisited. Schizophr Res (2005) 1.74
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biol Psychiatry (2012) 1.69
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry (2003) 1.66
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry (2002) 1.63
Depression-related variation in brain morphology over 3 years: effects of stress? Arch Gen Psychiatry (2008) 1.61
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry (2010) 1.61
A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry (2006) 1.57
Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects. Biol Psychiatry (2003) 1.55
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry (2012) 1.55
Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci (2008) 1.53
Multivariate network analysis of fiber tract integrity in Alzheimer's disease. Neuroimage (2006) 1.52
Response and remission criteria in major depression--a validation of current practice. J Psychiatr Res (2010) 1.52
Syndromes and phenomenological subtypes underlying acute mania: a factor analytic study of 576 manic patients. Am J Psychiatry (2002) 1.51
Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract (2012) 1.49
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry (2013) 1.48
Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry (2004) 1.48
Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry (2010) 1.46
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry. Brain (2004) 1.45
Progression of corpus callosum atrophy in Alzheimer disease. Arch Neurol (2002) 1.44
Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia. J Clin Psychopharmacol (2003) 1.43
Suicidality as rare adverse event of antidepressant medication: report from the AMSP multicenter drug safety surveillance project. J Clin Psychiatry (2010) 1.41
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol (2002) 1.41
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry (2002) 1.38
Enlargement of the amygdala in patients with a first episode of major depression. Biol Psychiatry (2002) 1.38
Ethical aspects of publishing. World J Biol Psychiatry (2006) 1.37
Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification. Schizophr Bull (2011) 1.36
Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J Psychiatry Neurosci (2006) 1.35
Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci (2004) 1.34
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry (2013) 1.34
Use of brief depression screening tools in primary care: consideration of heterogeneity in performance in different patient groups. Gen Hosp Psychiatry (2004) 1.34
Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition. Depress Anxiety (2007) 1.32
Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease. Ann Neurol (2002) 1.29
White matter microstructure underlying default mode network connectivity in the human brain. Neuroimage (2009) 1.29
Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry (2002) 1.28
Personality and attempted suicide. Analysis of anger, aggression and impulsivity. J Psychiatr Res (2009) 1.26
Is the PANSS used correctly? a systematic review. BMC Psychiatry (2011) 1.22
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res (2010) 1.22
Functional connectivity bias of the orbitofrontal cortex in drug-free patients with major depression. Biol Psychiatry (2010) 1.22
Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. J Clin Psychiatry (2002) 1.19
Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia. J Clin Psychiatry (2007) 1.19
Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome. Am J Psychiatry (2003) 1.19
Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol Psychiatry (2004) 1.17
The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. J Neurosci (2011) 1.14
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. J Affect Disord (2008) 1.13
Childhood stress, serotonin transporter gene and brain structures in major depression. Neuropsychopharmacology (2010) 1.12
Functional connectivity of emotional processing in depression. J Affect Disord (2011) 1.11
Reduced early auditory evoked gamma-band response in patients with schizophrenia. Biol Psychiatry (2009) 1.11
Failure to replicate effect of Kibra on human memory in two large cohorts of European origin. Am J Med Genet B Neuropsychiatr Genet (2008) 1.11
Sound level dependence of the primary auditory cortex: Simultaneous measurement with 61-channel EEG and fMRI. Neuroimage (2005) 1.11
Screening for depression in primary care: will one or two items suffice? Eur Arch Psychiatry Clin Neurosci (2004) 1.10
Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state. Schizophr Bull (2010) 1.10
Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study. J Psychiatr Res (2005) 1.10
Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study. Neuroimage (2007) 1.10
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia. World J Biol Psychiatry (2006) 1.10
Is the significant superiority of escitalopram compared with other antidepressants clinically relevant? Int Clin Psychopharmacol (2009) 1.09
A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Hum Mol Genet (2010) 1.08
Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry (2004) 1.08
Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol (2007) 1.07
A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits. Biol Psychiatry (2003) 1.07
Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project. J Clin Psychiatry (2010) 1.07
Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism. Schizophr Res (2007) 1.07
Convergent Findings of Altered Functional and Structural Brain Connectivity in Individuals with High Functioning Autism: A Multimodal MRI Study. PLoS One (2013) 1.07
Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI. J Neurol (2006) 1.07
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence. World J Biol Psychiatry (2011) 1.06
Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry study. Cereb Cortex (2006) 1.05
Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance. Am J Med Genet B Neuropsychiatr Genet (2010) 1.05
Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial. J Clin Psychopharmacol (2008) 1.04
Theta burst stimulation of the prefrontal cortex: safety and impact on cognition, mood, and resting electroencephalogram. Biol Psychiatry (2008) 1.04
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression. World J Biol Psychiatry (2002) 1.04
Prediction of treatment response in major depression: integration of concepts. J Affect Disord (2006) 1.04
Single-trial coupling of EEG and fMRI reveals the involvement of early anterior cingulate cortex activation in effortful decision making. Neuroimage (2008) 1.04
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias. World J Biol Psychiatry (2011) 1.04
Associations between trait impulsivity and prepotent response inhibition. J Clin Exp Neuropsychol (2012) 1.04
Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder. Biol Psychiatry (2003) 1.04
The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophr Res (2003) 1.04
White matter microstructure in relation to education in aging and Alzheimer's disease. J Alzheimers Dis (2009) 1.03
Use of neuroanatomical pattern regression to predict the structural brain dynamics of vulnerability and transition to psychosis. Schizophr Res (2010) 1.03